Received Jul 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
diarrhea; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of diarrhea in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix on an unknown date). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced diarrhea (Verbatim: diarrhea). The outcome of the diarrhea was resolved (duration 1 week). It was unknown if the reporter considered the diarrhea to be related to Shingles vaccine. It was unknown if the company considered the diarrhea to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 30-JUN-2025 and 02-JUL-2025 This case was reported by a patient via interactive digital media. The side effects of the shot can be rough. The patient got the second shot and had diarrhea for a week. No other information known at this time.